These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4366110)

  • 1. A study of the renin-angiotensin system in the nephrotic syndrome.
    Medina A; Davies DL; Brown JJ; Fraser R; Lever AF; Mallick NP; Morton JJ; Robertson JI; Tree M
    Nephron; 1974; 12(4):233-40. PubMed ID: 4366110
    [No Abstract]   [Full Text] [Related]  

  • 2. The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II.
    Düsing R; Vetter H; Kramer HJ
    Nephron; 1980; 25(4):187-92. PubMed ID: 6990285
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the renin-angiotensin system and the blood volume in the nephrotic syndrome.
    Yoo HD; Choi KS; Jung MH; Lee WS; Lee JW; Lee SR; Kim JS; Cho WK
    Korean J Intern Med; 1986 Jan; 1(1):72-7. PubMed ID: 15759380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a diuretically-active pyrazolone derivative on renin activity, plasma angiotensin II and aldesterone concentration in healthy subjects].
    Küppers H; Schnurr E; Grabensee B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():302-5. PubMed ID: 611971
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the renin-angiotensin-aldosterone system involved in the sodium retention in the nephrotic syndrome?
    Brown EA; Markandu ND; Roulston JE; Jones BE; Squires M; MacGregor GA
    Nephron; 1982; 32(2):102-7. PubMed ID: 6757778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of electrolyte excretion, renin activity, angiotensin-II and aldosterone concentrations during administration of 3-amino-1-(3,4-dichloro-a-methyl-benzyl)-2-pyrazolin-5-one (Bay g 2821).
    Schnurr E; Küppers H
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):453-6. PubMed ID: 511420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man.
    Oelkers W; Schöneshöfer M; Blümel A
    J Clin Endocrinol Metab; 1974 Nov; 39(5):882-90. PubMed ID: 4370810
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma renin and angiotensinogen levels in pathological states associated with oedema.
    Imai M; Sokabe H
    Arch Dis Child; 1968 Aug; 43(230):475-9. PubMed ID: 4299072
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between plasma renin, renin-substrate, angiotensin II, aldosterone and electrolytes in normal pregnancy.
    Wier RJ; Brown JJ; Fraser R; Lever AF; Logan RW; McIlwaine GM; Morton JJ; Robertson JI; Tree M
    J Clin Endocrinol Metab; 1975 Jan; 40(1):108-15. PubMed ID: 234473
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma renin, angiotensin II, and plasma and urinary aldosterone in running exercise.
    Kosunen KJ; Pakarinen AJ
    J Appl Physiol; 1976 Jul; 41(1):26-9. PubMed ID: 972128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin-aldosterone system in patients with chronic primary glomerular diseases.
    Tanaka T; Hashimoto H; Ohba H; Abe M; Yagi S
    Nihon Jinzo Gakkai Shi; 1986 Sep; 28(9):1261-6. PubMed ID: 3546877
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
    Paton AM; Lever AF; Oliver NW; Medina A; Briggs JD; Morton JJ; Brown JJ; Robertson JI; Fraser R; Tree M; Gavras H
    Clin Nephrol; 1975 Jan; 3(1):18-23. PubMed ID: 1126059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated renin-angiotensin-aldosterone system and its effects on cardiovascular system during 20-days horizontal bed rest.
    Haruna Y; Suzuki Y; Yanagibori R; Kawakubo K; Gunji A
    J Gravit Physiol; 1995; 2(1):P27-8. PubMed ID: 11538920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renin-angiotensin-aldosterone system in acute embologenic arterial obstruction].
    Tenedieva VD; Isaev MR
    Kardiologiia; 1979 Mar; 19(3):55-61. PubMed ID: 430958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma renin activity, angiotensin II, and aldosterone during the hypnotic suggestion of running.
    Kosunen KJ; Kuoppasalmi K; Näveri H; Rehunen S; Närvänen S; Adlercreutz H
    Scand J Clin Lab Invest; 1977 Apr; 37(2):99-103. PubMed ID: 616045
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of aldosterone in the sodium retention of patients with nephrotic syndrome.
    Shapiro MD; Hasbargen J; Hensen J; Schrier RW
    Am J Nephrol; 1990; 10(1):44-8. PubMed ID: 2188506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease.
    Weidmann P; Maxwell MH; Rowe P; Winer R; Massry SG
    Nephron; 1975; 15(1):35-49. PubMed ID: 165438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.
    Dzau VJ; Colucci WS; Hollenberg NK; Williams GH
    Circulation; 1981 Mar; 63(3):645-51. PubMed ID: 7006851
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin activity, plasma angiotensin and plasma and urinary electrolytes in normal and toxaemic pregnancy, including a prospective study.
    Gordon RD; Symonds EM; Wilmshurst EG; Pawsey CG
    Clin Sci; 1973 Jul; 45(1):115-27. PubMed ID: 4352497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.